Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

Heejoon Jang; Won Kim

doi:10.3350/cmh.2025.0533

Articles

Page Path

Reply to Correspondence

Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

Heejoon Jang, Won Kim

DOI: https://doi.org/10.3350/cmh.2025.0533 [Accepted]

Published online: June 9, 2025

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea

Corresponding author: Won Kim, Tel: +82-2-870-2233,
Email: drwon1@snu.ac.kr

Received: 14 May 2025 • Accepted: 4 June 2025

2,291 Views
15 Download
0 Crossref
0 Scopus

Full Article

Download PDF

Citations

Citations to this article as recorded by

Cite

CITE

export

Copy Download

Format

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

DOI: https://doi.org/10.3350/cmh.2025.0533

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
bib — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

DOI: https://doi.org/10.3350/cmh.2025.0533

Articles

Page Path

Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

Full Article

Citations

CITE

Download Citation

Format:

Include:

Related articles

ABOUT

BROWSE ARTICLES

FOR CONTRIBUTORS